Bridgewest Group Venture Capital VC portfolio companies

Automated Manufacturing of CAR-T cell

BioOra Limited is a partnership between Bridgewest Ventures and the Malaghan Institute of Medical Research. Through automated manufacturing of CAR-T cell immunotherapy, BioOra can deliver life-saving immunotherapies at substantially less cost.

2021 year invested
John Robson,
Managing Director ›

Software Test Automation

A Bridgewest Ventures New Zealand Incubator company that delivers a test automation platform, SaaS, and ERP automated testing and release management, leveraging AI to lower costs and de-risk software upgrade acceptance.

2021 year invested
Dan Diefendorf,
Chair and CEO ›

AI Solutions & Services

Pioneering advancements in Artificial Intelligence leverage expert data science for AI algorithms and IOT smart devices from edge to cloud, that garner meaningful sensory data insights and establish critical building blocks for ethical AI.

2021 year invested
Saba Samiei,
Founder and President ›

Bionanorod-based Immunodiagnostics

Pioneers of the biological scalable nanorod technology platform with applications in immunodiagnostics.

2022 year invested
Paul Smith, CEO ›

Biotechnology Company

A biotechnology company leveraging patented 3D printed chromatography columns for separating and purifying biological molecules from a fluid mixture. Serving the medicinal therapeutics industry, enabling purification of DNA, RNA, viruses, and antibodies used in vaccines and cell and gene therapies.

2022 year invested
Dr. Sean Feast, CEO ›

Surgical Tools

A medical technology company with a novel revascularization device to help plastic surgeons restore form and function for patients who are left disfigured from disease and deformity.

2022 year invested
Dr. Nandoun Abeysekera, CEO ›

Ophthalmic Therapeutics

TheiaNova is developing transformative, new, non-invasive therapies for patients with vision impairment due to ectatic vision disorders.

2022 year invested
Dr. Carissa Fonseca, CEO ›

Sustainable Plastics Manufacturing

Compostify creates certified, home-compostable bioplastics that decompose within a year, restoring soil nutrients without leaving microplastics. Backed by Scion, their solutions set a global standard for sustainable plastics.

2024 year invested
Steve Wilson, CEO, Founder ›

Skin Cancer Screening Tool

Luminoma is pioneering a non-invasive skin cancer screening tool. By detecting molecular changes in cells, Luminoma delivers rapid and accurate diagnosis, reducing patient stress and healthcare system burden.

2023 year invested
Maher Khaled, CEO, Founder ›

Sustainable Bio-Performance

A future-driven bio-based foamed material platform that addresses the global plastics crisis by enabling current polystyrene factory equipment to mold a sustainably sourced, functional replacement for Styrofoam with potential for multiple end of life options.

2023 year invested
Sarah Heine, CEO ›

Battery Materials

High-performance materials that provide significant improvements in energy density, capacity retention and scalability for next-generation batteries.

2025 year invested
Will Haringa,
Commercial Lead ›

Our Investment Portfolio